Lindbrook Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

$1.09 Billion
Q4 2024

A detailed history of Lindbrook Capital, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 535 shares of ARWR stock, worth $10,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

535

Previous 156 242.95%

Holding current value

$10,223

Previous $3,000 233.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$17.7 - $26.34 $6,708 - $9,982	379 Added 242.95%	535 $10,000
Q3 2024 Nov 01, 2024	SELL	$19.36 - $29.54 $6,834 - $10,427	-353 Reduced 69.35%	156 $3,000
Q2 2024 Jul 31, 2024	BUY	$21.87 - $28.24 $7,938 - $10,251	363 Added 248.63%	509 $13,000
Q1 2024 Apr 25, 2024	SELL	$27.21 - $39.48 $5,414 - $7,856	-199 Reduced 57.68%	146 $4,000
Q4 2023 Jan 31, 2024	SELL	$21.2 - $31.03 $1,780 - $2,606	-84 Reduced 19.58%	345 $10,000
Q3 2023 Oct 25, 2023	BUY	$26.2 - $36.08 $3,563 - $4,906	136 Added 46.42%	429 $11,000
Q2 2023 Jul 28, 2023	BUY	$25.16 - $41.38 $2,490 - $4,096	99 Added 51.03%	293 $10,000
Q1 2023 Apr 26, 2023	SELL	$23.68 - $38.51 $11,224 - $18,253	-474 Reduced 70.96%	194 $4,000
Q4 2022 Jan 24, 2023	SELL	$28.0 - $40.56 $1,624 - $2,352	-58 Reduced 7.99%	668 $0
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $207 - $338	7 Added 0.97%	726 $24,000
Q2 2022 Aug 01, 2022	BUY	$27.79 - $50.61 $27 - $50	1 Added 0.14%	719 $25,000
Q1 2022 Apr 21, 2022	SELL	$39.62 - $69.97 $16,878 - $29,807	-426 Reduced 37.24%	718 $33,000
Q4 2021 Jan 18, 2022	BUY	$58.09 - $82.51 $65,815 - $93,483	1,133 Added 10300.0%	1,144 $76,000
Q3 2021 Nov 05, 2021	BUY	$58.38 - $84.96 $642 - $934	11 New	11 $1,000
Q2 2021 Jul 27, 2021	SELL	$62.15 - $90.32 $13,237 - $19,238	-213 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$61.35 - $90.47 $13,067 - $19,270	213 New	213 $14,000
Q4 2020 Jan 27, 2021	SELL	$43.82 - $85.37 $43,820 - $85,370	-1,000 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$33.21 - $51.27 $33,210 - $51,270	1,000 New	1,000 $43,000
Q2 2020 Jul 27, 2020	BUY	$26.12 - $43.27 $0 - $0	0 New	0 $0
Q1 2020 Apr 22, 2020	SELL	$20.56 - $63.12 $10,588 - $32,506	-515 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$28.14 - $73.01 $27,717 - $71,914	-985 Reduced 65.67%	515 $33,000
Q2 2019 Jul 24, 2019	SELL	$17.43 - $28.82 $43,575 - $72,050	-2,500 Reduced 62.5%	1,500 $39,000
Q1 2019 Apr 23, 2019	SELL	$12.05 - $20.18 $2,410 - $4,036	-200 Reduced 4.76%	4,000 $73,000
Q4 2018 Feb 07, 2019	BUY	$10.74 - $19.7 $45,108 - $82,740	4,200 New	4,200 $52,000

Others Institutions Holding ARWR

# of Institutions

298

Shares Held

91.8M

Call Options Held

199K

Put Options Held

453K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.02B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History